Search Results - "Prostatic Neoplasms/mortality"
-
1
Authors: et al.
Source: Zaguán. Repositorio Digital de la Universidad de Zaragoza
Universidad de ZaragozaSubject Terms: Aged, 80 and over, Male, Persona de Mediana Edad, Anciano, España, Prostatic Neoplasms, Neoplasias de la Próstata, Middle Aged, Estudios Longitudinales, Sistema de Registros, Magnetic Resonance Imaging, Anciano de 80 o más Años, Humanos, Spain, Humans, Aged Aged, 80 and over Humans Longitudinal Studies Magnetic Resonance Imaging Male Middle Aged Prostatic Neoplasms* / diagnosis Prostatic Neoplasms* / epidemiology Prostatic Neoplasms* / mortality Prostatic Neoplasms* / pathology Prostatic Neoplasms* / therapy Registries Spain / epidemiology Watchful Waiting* / statistics & numerical data, Longitudinal Studies, Registries, Espera Vigilante, Watchful Waiting, Masculino, Imagen por Resonancia Magnética, Aged
File Description: application/pdf
-
2
Authors: et al.
Source: Acta Oncol
Acta Oncologica, Vol 63, Iss 1 (2024)
Hyldgaard, J M, Nørgaard, M, Hjort, P B & Jensen, J B 2024, 'Bladder cancer incidence and mortality among men with and without castration therapy for prostate cancer-a nation-wide cohort study', Acta Oncologica, vol. 63, pp. 746-754. https://doi.org/10.2340/1651-226X.2024.40969Subject Terms: Male, Denmark, Urinary Bladder Cancer, Cohort Studies, androgen receptor, gender, Humans, Registries, Prostatic Neoplasms/mortality, RC254-282, Aged, Aged, 80 and over, Incidence, Registries/statistics & numerical data, antihormonal treatment, Gender, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Androgen Antagonists, Middle Aged, Denmark/epidemiology, Androgen receptor, Urinary Bladder Neoplasms, Urinary Bladder Neoplasms/mortality, Anti-hormonal Treatment, Urinary bladder cancer, Original Article, Androgen Antagonists/therapeutic use, Orchiectomy
-
3
Authors: et al.
Source: Ann Surg Oncol
Subject Terms: Male, Adult, Leiomyosarcoma, Prostatectomy, Prostatic Neoplasms, Sarcoma, Middle Aged, Prognosis, Cancer-specific mortality, Mesenchymal tumor, Prostate cancer, SEER, Variant histology, Combined Modality Therapy, Survival Rate, Rhabdomyosarcoma, Humans, Original Article, Aged [MeSH], Prostatic Neoplasms/mortality [MeSH], Prostatic Neoplasms/pathology [MeSH], Sarcoma/mortality [MeSH], Leiomyosarcoma/therapy [MeSH], Male [MeSH], Sarcoma/therapy [MeSH], Combined Modality Therapy [MeSH], Follow-Up Studies [MeSH], Leiomyosarcoma/mortality [MeSH], SEER Program [MeSH], Adult [MeSH], Humans [MeSH], Leiomyosarcoma/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Survival Rate [MeSH], Sarcoma/pathology [MeSH], Prostatectomy/mortality [MeSH], Rhabdomyosarcoma/therapy [MeSH], Prognosis [MeSH], Prostatic Neoplasms/therapy [MeSH], Rhabdomyosarcoma/mortality [MeSH], Rhabdomyosarcoma/pathology [MeSH], SEER Program, Aged, Follow-Up Studies, Retrospective Studies
-
4
Authors: et al.
Source: Int J Clin Oncol
Subject Terms: Male, Antineoplastic Combined Chemotherapy Protocols, Network Meta-Analysis, Androgen Receptor Antagonists, Humans, Prostatic Neoplasms, Androgen Antagonists, Review Article, Docetaxel, Androgen Receptor Antagonists/therapeutic use [MeSH], Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Prostatic Neoplasms/drug therapy [MeSH], Prostatic Neoplasms/pathology [MeSH], Metastatic hormone-sensitive prostate cancer, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Androgen Antagonists/therapeutic use [MeSH], Low-volume, Randomized Controlled Trials as Topic [MeSH], Docetaxel/therapeutic use [MeSH], High-volume, Androgen receptor signaling inhibitor, Male [MeSH], Tumor Burden [MeSH], Docetaxel/administration, Randomized Controlled Trials as Topic, Tumor Burden, 3. Good health
Access URL: https://pubmed.ncbi.nlm.nih.gov/38582807
https://link.springer.com/content/pdf/10.1007/s10147-024-02485-4.pdf
https://doi.org/10.1007/s10147-024-02485-4
https://link.springer.com/article/10.1007/s10147-024-02485-4
https://doi.org/10.1007/s10147-024-02485-4
https://link.springer.com/article/10.1007/s10147-024-02485-4
https://ruj.uj.edu.pl/handle/item/353173
https://repository.publisso.de/resource/frl:6501090 -
5
Authors: et al.
Source: Prostate Cancer Prostatic Dis
Subject Terms: Male, ANTIGEN, Article, 3211 Oncology and carcinogenesis, Biomarkers, Tumor, Humans, 1112 Oncology and Carcinogenesis, FUNCTIONAL OUTCOMES, Aged, Retrospective Studies, Prostatectomy, Salvage Therapy, Science & Technology, 3202 Clinical sciences, Prostatic Neoplasms, ADENOCARCINOMA, MEN, Urology & Nephrology, Prostate-Specific Antigen, Middle Aged, Prognosis, CANCER, 3. Good health, Oncology, PREDICTIVE FACTORS, SURVIVAL, Neoplasm Recurrence, Local, Follow-Up Studies [MeSH], Neoplasm Recurrence, Local/blood [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Salvage Therapy [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], Neoplasm Recurrence, Local/surgery [MeSH], Male [MeSH], 692/699/67/589/466, Biomarkers, Tumor/blood [MeSH], Prognosis [MeSH], 692/699/2768/1753/466, Prostatic Neoplasms/surgery [MeSH], Prostatectomy/methods [MeSH], article, Life Sciences & Biomedicine, DETECTABLE PSA, Follow-Up Studies
File Description: application/pdf
-
6
Authors: et al.
Source: World J Urol
Subject Terms: Male, Prostatectomy, Survival Rate, Research, Quality of Life, Humans, Prostatic Neoplasms, EORTC QLQ-C30, Health-related quality of life, Aged [MeSH], Risk Assessment [MeSH], Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Prospective Studies [MeSH], Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Radical prostatectomy, Survival Rate [MeSH], Metastasis-free survival, Male [MeSH], Risk stratification, Quality of Life [MeSH], Intermediate-risk prostate cancer, Prognosis [MeSH], Prostatic Neoplasms/psychology [MeSH], Prostatic Neoplasms/surgery [MeSH], Prostatectomy/methods [MeSH], Prospective Studies, Middle Aged, Prognosis, Risk Assessment, Aged
-
7
Authors: et al.
Source: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-16 (2024)Subject Terms: Male, Adult, Proximal femoral metastasis, Bone Neoplasms, Breast Neoplasms, Osteolysis, Kaplan-Meier Estimate, Humans, Femur, RC254-282, Aged, Retrospective Studies, Aged, 80 and over, Osteolytic bone lesions, Aged, 80 and over [MeSH], Femoral Neoplasms/radiotherapy [MeSH], Radiotherapy, Adjuvant/methods [MeSH], Aged [MeSH], Prostatic Neoplasms/mortality [MeSH], Radiotherapy, Adjuvant/adverse effects [MeSH], Prostatic Neoplasms/pathology [MeSH], Femoral Neoplasms/secondary [MeSH], Breast Neoplasms/radiotherapy [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Osteolysis/etiology [MeSH], Multimodal cancer therapies, Fractures, Spontaneous/surgery [MeSH], Palliative Care/methods [MeSH], Bone Neoplasms/surgery [MeSH], Male [MeSH], Breast Neoplasms/surgery [MeSH], Prostatic Neoplasms/surgery [MeSH], Breast Neoplasms/mortality [MeSH], Breast Neoplasms/pathology [MeSH], Bone Neoplasms/radiotherapy [MeSH], Female [MeSH], Adult [MeSH], Intramedullary nailing, Kaplan-Meier Estimate [MeSH], Humans [MeSH], Fractures, Spontaneous/etiology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Impending fracture, Skeletal-related events, Femur/surgery [MeSH], Femur/pathology [MeSH], Bone Neoplasms/secondary [MeSH], Femoral Neoplasms/mortality [MeSH], Bone Neoplasms/mortality [MeSH], Pathological fracture, Femur/radiation effects [MeSH], Research, Femoral Neoplasms/surgery [MeSH], Femoral Neoplasms, Palliative Care, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Middle Aged, Fractures, Spontaneous, Female, Radiotherapy, Adjuvant
-
8
Authors: et al.
Contributors: et al.
Source: JNCI Cancer Spectr
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Dipòsit Digital de la UB
instname
RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
Universidad Pontificia de Salamanca
Cariolou, M, Christakoudi, S, Gunter, M J, Key, T, Pérez-Cornago, A, Travis, R, Zamora-Ros, R, Petersen, K E T, Tjønneland, A, Weiderpass, E, Kaaks, R, Seibold, P, Inan-Eroglu, E, Schulze, M B, Masala, G, Agnoli, C, Tumino, R, Di Girolamo, C, Aizpurua, A, Rodriguez-Barranco, M, Santiuste, C, Guevara, M, Aune, D, Chan, D S M, Muller, D C & Tsilidis, K K 2024, ' Adiposity assessed close to diagnosis and prostate cancer prognosis in the EPIC study ', JNCI Cancer Spectrum, vol. 8, no. 5 . https://doi.org/10.1093/jncics/pkae070Subject Terms: Male, History, Neoplasias de la próstata, Pronòstic mèdic, Índice de masa corporal, Article, Europe/epidemiology, Body Mass Index, Association, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Cause of Death, Diagnosis, Humans, Disease, Prospective Studies, Obesity, Prostatic Neoplasms/mortality, Adiposity, Proportional Hazards Models, Aged, 2. Zero hunger, Prostate cancer, Càncer de pròstata, Interleukin-6, Waist-Hip Ratio, Prostatic Neoplasms, Middle Aged, Modelos de riesgos proporcionales, Prognosis, Interleukin-10, 3. Good health, Europe, Obesitat, Obesity/complications, Waist Circumference
File Description: application/pdf
-
9
Authors: et al.
Source: BMC Urol
BMC Urology, Vol 24, Iss 1, Pp 1-10 (2024)Subject Terms: Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Germany, Person years life lost, Middle Aged [MeSH], Time Factors [MeSH], Germany/epidemiology [MeSH], Mortality, Male [MeSH], Research, North Rhine-Westphalia, Proportional mortality ratio, Cancer registry, Prostate cancer, Male, Aged, 80 and over, Adult, Time Factors, Medizin, Prostatic Neoplasms, Middle Aged, Diseases of the genitourinary system. Urology, 3. Good health, Humans, RC870-923, Aged
-
10
Authors: et al.
Source: Int Urol Nephrol
Subject Terms: Male, Pulmonary and Respiratory Medicine, Cumulative incidence, Mortality Rates, Hazard ratio, Urology, Population, External beam radiotherapy, Proportional hazards model, Risk Assessment, Cancer-specific survival, High-risk prostate cancer, Hispanic–Latino race/ethnicity, Radical prostatectomy, Aged, Hispanic or Latino, Humans, Middle Aged, Prostatectomy, Prostatic Neoplasms, Retrospective Studies, 03 medical and health sciences, Advancements in Prostate Cancer Research, 0302 clinical medicine, Hispanic or Latino [MeSH], Aged [MeSH], Risk Assessment [MeSH], Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Male [MeSH], Prostatic Neoplasms/therapy [MeSH], Prostatectomy [MeSH], Urology - Original Paper, Global Cancer Incidence and Mortality Patterns, Propensity score matching, Health Sciences, Internal medicine, Cancer, ddc:610, Prostate cancer, Prostate Cancer, Incidence (geometry), Physics, Confidence interval, Cohort, Prostate Cancer Research and Treatment, Optics, 3. Good health, Radiation therapy, cancer-specific survival, external beam radiotherapy, high-risk prostate cancer, hispanic–latino race/ethnicity, radical prostatectomy, Environmental health, Oncology, Gynecology, Survival Rates, Medicine
File Description: application/pdf
Access URL: https://link.springer.com/content/pdf/10.1007/s11255-021-03055-7.pdf
https://pubmed.ncbi.nlm.nih.gov/34783982
https://pubmed.ncbi.nlm.nih.gov/34783982/
https://moh-it.pure.elsevier.com/en/publications/cancer-specific-mortality -after-radical-prostatectomy-vs-external
https://www.ncbi.nlm.nih.gov/pubmed/34783982
https://paperity.org/p/275742213/cancer-specific-mortality -after-radical-prostatectomy-vs-external-beam-radiotherapy-in
https://hdl.handle.net/11573/1639439
https://doi.org/10.1007/s11255-021-03055-7
https://repository.publisso.de/resource/frl:6445896 -
11
Authors: et al.
Contributors: et al.
Source: RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
instnameSubject Terms: Prostatic Neoplasms / pathology, Thiohydantoins / administration & dosage, Male, 0301 basic medicine, Prostatic Neoplasms / complications, Fatigue / diagnosis, Abiraterone Acetate, Severity of Illness Index, prostatic neoplasms, Chemotherapy-Naive Patients, neoplasm metastasis, 0302 clinical medicine, Pain Measurement / statistics & numerical data, Cancer Pain / diagnosis, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Fatigue / drug therapy, apalutamide, Fatigue, Quality of Life, Pain Measurement, Fatigue / psychology, Aged, 80 and over, Patient, Double-blind, Men, Cancer Pain, Middle Aged, Progression-Free Survival, Abiraterone acetate, 3. Good health, Chemotherapy-naive patients, Thiohydantoins, Double-Blind, Adult, 03 medical and health sciences, Cancer Pain / etiology, Prostatic Neoplasms / mortality, Prostatic Neoplasms / drug therapy, Humans, Patient Reported Outcome Measures, Antineoplastic Combined Chemotherapy Protocols / administration & dosage, Cancer Pain / drug therapy, Aged, Clinical Deterioration, Prostatic Neoplasms, Androgen Antagonists, Cancer Pain / psychology, Fatigue / etiology, quality of life, Prednisone, Androgen Antagonists / administration & dosage, Follow-Up Studies
File Description: application/pdf
Access URL: https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000001841
https://pubmed.ncbi.nlm.nih.gov/34039013
https://hdl.handle.net/10668/25041
https://www.ncbi.nlm.nih.gov/pubmed/34039013
https://europepmc.org/article/MED/34039013
https://lup.lub.lu.se/search/publication/d9b45cb0-ee40-4ad0-a9a7-d7ec23e9fa17
https://www.auajournals.org/doi/10.1097/JU.0000000000001841
https://pubmed.ncbi.nlm.nih.gov/34039013/
https://portal.research.lu.se/en/publications/apalutamide-plus-androgen-deprivation-therapy-for-metastatic-cast -
12
Authors: et al.
Source: World J Urol
Subject Terms: Male, Other-cause mortality, External beam radiotherapy, Bone Neoplasms, Race/ethnicity, White People, Metastatic prostate cancer, 03 medical and health sciences, 0302 clinical medicine, Aged [MeSH], Prostatic Neoplasms/mortality [MeSH], Bone Neoplasms/ethnology [MeSH], Carcinoma/radiotherapy [MeSH], Carcinoma/ethnology [MeSH], Prostatic Neoplasms/pathology [MeSH], Carcinoma/secondary [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Original Article, Male [MeSH], White People/statistics, Black or African American/statistics, Propensity Score [MeSH], Mortality/ethnology [MeSH], Carcinoma/mortality [MeSH], SEER Program [MeSH], Hispanic or Latino/statistics, Humans [MeSH], Prostatic Neoplasms/ethnology [MeSH], Middle Aged [MeSH], Survival Rate [MeSH], Bone Neoplasms/secondary [MeSH], Bone Neoplasms/mortality [MeSH], Cancer-specific mortality, Asian/statistics, Radiotherapy [MeSH], Humans, Mortality, Propensity Score, Aged, 2. Zero hunger, Asian, Radiotherapy, Carcinoma, Prostatic Neoplasms, Hispanic or Latino, Middle Aged, 3. Good health, Black or African American, Survival Rate, SEER Program
Access URL: https://link.springer.com/content/pdf/10.1007/s00345-021-03720-7.pdf
https://pubmed.ncbi.nlm.nih.gov/33978812
https://hdl.handle.net/11588/977899
https://link.springer.com/content/pdf/10.1007/s00345-021-03720-7.pdf
https://link.springer.com/article/10.1007/s00345-021-03720-7
https://www.ncbi.nlm.nih.gov/pubmed/33978812
https://europepmc.org/article/MED/33978812
https://repository.publisso.de/resource/frl:6447715 -
13
Authors: et al.
Source: World J Urol
Subject Terms: Male, Prostatectomy, 2. Zero hunger, ddc:610, Clinical Decision-Making [MeSH], Watchful Waiting [MeSH], Aged [MeSH], Risk Assessment [MeSH], Prostatic Neoplasms/mortality [MeSH], Kaplan-Meier Estimate [MeSH], Humans [MeSH], Active surveillance, Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Radical prostatectomy, Original Article, Chemotherapy, Adjuvant [MeSH], Proportional Hazards Models [MeSH], Male [MeSH], Disease-Free Survival [MeSH], Prostatic Neoplasms/therapy [MeSH], Antineoplastic Agents, Hormonal/therapeutic use [MeSH], Favorable intermediate risk, Prostatectomy [MeSH], Radiotherapy, Adjuvant [MeSH], Oncological outcome, Prostate cancer, Antineoplastic Agents, Hormonal, Clinical Decision-Making, Prostatic Neoplasms, Kaplan-Meier Estimate, Middle Aged, Risk Assessment, Disease-Free Survival, ddc, 3. Good health, Chemotherapy, Adjuvant, Humans, Radiotherapy, Adjuvant, Watchful Waiting, Aged, Proportional Hazards Models
File Description: application/pdf
Access URL: https://link.springer.com/content/pdf/10.1007/s00345-021-03717-2.pdf
https://pubmed.ncbi.nlm.nih.gov/33973043
https://link.springer.com/content/pdf/10.1007/s00345-021-03717-2.pdf
https://link.springer.com/article/10.1007/s00345-021-03717-2
https://www.ncbi.nlm.nih.gov/pubmed/33973043
https://europepmc.org/article/MED/33973043
https://pubmed.ncbi.nlm.nih.gov/33973043/
http://www.ncbi.nlm.nih.gov/pubmed/33973043
https://nbn-resolving.org/urn:nbn:de:bvb:384-opus4-920802
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/92080
https://doi.org/10.1007/s00345-021-03717-2
https://opus.bibliothek.uni-augsburg.de/opus4/files/92080/Meissner2021_Long-termAndPathologicalOutcom.pdf
https://repository.publisso.de/resource/frl:6447733
https://mediatum.ub.tum.de/doc/1638242/document.pdf -
14
Authors: et al.
Source: World J Urol
Subject Terms: Male, Prostatectomy, ddc:610, Hormone-sensitivity, Aged [MeSH], Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Treatment Outcome [MeSH], Metastatic prostate cancer, Prostatic Neoplasms, Castration-Resistant/prevention, Prostatic Neoplasms/drug therapy [MeSH], Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Castration resistance, Androgen Antagonists/therapeutic use [MeSH], Original Article, Survival Rate [MeSH], Androgen deprivation treatment, Male [MeSH], Prostatectomy [MeSH], Prostatic Neoplasms/surgery [MeSH], Time Factors, Prostatic Neoplasms, Androgen Antagonists, Middle Aged, 3. Good health, Survival Rate, Prostatic Neoplasms, Castration-Resistant, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Humans, Neoplasm Metastasis, Aged
Access URL: https://link.springer.com/content/pdf/10.1007/s00345-020-03568-3.pdf
https://pubmed.ncbi.nlm.nih.gov/33502558
https://www.ncbi.nlm.nih.gov/pubmed/33502558
https://link.springer.com/content/pdf/10.1007/s00345-020-03568-3.pdf
https://link.springer.com/article/10.1007/s00345-020-03568-3
https://europepmc.org/article/MED/33502558
https://scidok.sulb.uni-saarland.de/handle/20.500.11880/31177
https://publikationen.sulb.uni-saarland.de/bitstream/20.500.11880/31177/1/Niklas2021_Article_CanLocalTreatmentProlongTheSen.pdf
https://repository.publisso.de/resource/frl:6451131 -
15
Authors: et al.
Source: Support Care Cancer
Subject Terms: Male, 03 medical and health sciences, 0302 clinical medicine, Cancer Survivors, 4. Education, Quality of Life, Humans, Prostatic Neoplasms, Original Article, Cancer Survivors/psychology [MeSH], Cancer survivor, Aged [MeSH], Posttraumatic growth, Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Quality of Life/psychology [MeSH], Benefit finding, Male [MeSH], Prostatic Neoplasms/psychology [MeSH], Prostate cancer, Urological malignancy, ddc, Aged, 3. Good health
File Description: application/pdf
Access URL: https://link.springer.com/content/pdf/10.1007/s00520-020-05971-3.pdf
https://pubmed.ncbi.nlm.nih.gov/33447865
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236447
https://pubmed.ncbi.nlm.nih.gov/33447865/
https://www.scilit.net/article/c897e426fd1e8d58140f2c09af2809bb?action=show-references
https://link.springer.com/article/10.1007/s00520-020-05971-3
https://link.springer.com/content/pdf/10.1007/s00520-020-05971-3.pdf
https://repository.publisso.de/resource/frl:6446694
https://mediatum.ub.tum.de/doc/1637986/document.pdf -
16
Authors: et al.
Source: World J Urol
Subject Terms: Male, Localised prostate cancer, Urban Health, Prostatic Neoplasms, Rural Health, Middle Aged, North American population, Aged [MeSH], Other cause mortality, Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Metastatic prostate cancer, Population density, Prostatic Neoplasms/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], SEER, Rural Health [MeSH], Original Article, Neoplasm Staging [MeSH], Male [MeSH], United States/epidemiology [MeSH], Urban Health [MeSH], United States, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, 11. Sustainability, Humans, Aged, Neoplasm Staging, Retrospective Studies
Access URL: https://link.springer.com/content/pdf/10.1007/s00345-020-03483-7.pdf
https://pubmed.ncbi.nlm.nih.gov/33155063
http://hdl.handle.net/11588/846540
https://www.ncbi.nlm.nih.gov/pubmed/33155063
https://link.springer.com/content/pdf/10.1007/s00345-020-03483-7.pdf
https://link.springer.com/article/10.1007/s00345-020-03483-7
https://hdl.handle.net/20.500.11768/108578
https://doi.org/10.1007/s00345-020-03483-7
https://repository.publisso.de/resource/frl:6466848 -
17
Authors: et al.
Source: World J Urol
Subject Terms: Male, Asian, Prostatic Neoplasms, Censuses, AANHPI, AAPI, Native Hawaiian, NHOPI, Pacific Islander, Prostate cancer survival, Racial disparities, SEER, Aged, Asian Americans, European Continental Ancestry Group, Humans, Middle Aged, Neoplasm Grading, Neoplasm Staging, Prognosis, Prostate-Specific Antigen, Retrospective Studies, United States, White People, Neoplasm Grading [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], United States [MeSH], Asian Americans/statistics, Prostatic Neoplasms/mortality [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Original Article, Neoplasm Staging [MeSH], Censuses [MeSH], Male [MeSH], Prostatic Neoplasms/classification [MeSH], European Continental Ancestry Group/statistics, Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Prognosis [MeSH], 3. Good health, 03 medical and health sciences, 0302 clinical medicine
File Description: application/pdf
Access URL: https://link.springer.com/content/pdf/10.1007/s00345-020-03242-8.pdf
https://pubmed.ncbi.nlm.nih.gov/32458094
https://link.springer.com/content/pdf/10.1007/s00345-020-03242-8.pdf
https://moh-it.pure.elsevier.com/en/publications/psa-stage-grade-and-prostate-cancer-specific-mortality -in-asian-a
https://link.springer.com/article/10.1007/s00345-020-03242-8
https://pubmed.ncbi.nlm.nih.gov/32458094/
http://europepmc.org/article/MED/32458094
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969699/
https://hdl.handle.net/2434/881545
https://doi.org/10.1007/s00345-020-03242-8
https://repository.publisso.de/resource/frl:6466830 -
18
Authors:
Source: Shelan, M.; Aebersold, D.; Ghadjar, P. (2020). [Early salvage radiation therapy of the prostate bed appears to be equally effective compared to adjuvant radiation therapy after radical prostatectomy]. Strahlentherapie und Onkologie, 196(4), pp. 406-409. Springer 10.1007/s00066-020-01591-2 <http://dx.doi.org/10.1007/s00066-020-01591-2>
Subject Terms: Male, Prostatectomy, Salvage Therapy, Prostatic Neoplasms, 610 Medicine & health, Middle Aged, Prostate-Specific Antigen, Combined Modality Therapy, Progression-Free Survival, 3. Good health, Survival Rate, 03 medical and health sciences, Hormone Antagonists, 0302 clinical medicine, Early Medical Intervention, Follow-Up Studies [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Early Medical Intervention [MeSH], Prostatic Neoplasms/mortality [MeSH], Humans [MeSH], Salvage Therapy [MeSH], Progression-Free Survival [MeSH], Hormone Antagonists/therapeutic use [MeSH], Prostatic Neoplasms/pathology [MeSH], Literatur Kommentiert, Middle Aged [MeSH], Oncology, Prostatic Neoplasms/radiotherapy [MeSH], Neoplasm Staging [MeSH], Survival Rate [MeSH], Male [MeSH], Prostatectomy [MeSH], Radiation Injuries/etiology [MeSH], Combined Modality Therapy [MeSH], Radiotherapy, Adjuvant [MeSH], Radiotherapy, Humans, Radiotherapy, Adjuvant, Radiation Injuries, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit, Aged, Follow-Up Studies, Neoplasm Staging
File Description: application/pdf
Access URL: https://link.springer.com/content/pdf/10.1007/s00066-020-01591-2.pdf
https://pubmed.ncbi.nlm.nih.gov/32060583
https://www.ncbi.nlm.nih.gov/pubmed/32060583
https://link.springer.com/article/10.1007/s00066-020-01591-2
https://pubmed.ncbi.nlm.nih.gov/32060583/
https://link.springer.com/content/pdf/10.1007/s00066-020-01591-2.pdf
https://boris.unibe.ch/140835/
https://repository.publisso.de/resource/frl:6441848
https://refubium.fu-berlin.de/handle/fub188/36410
https://doi.org/10.17169/refubium-36126
https://doi.org/10.1007/s00066-020-01591-2 -
19
Authors: et al.
Source: Gazeta Médica; NUMBER 1 · VOLUME 10 · JANUARY/MARCH 2023; 24-30 ; Gazeta Médica; NÚMERO 1 · VOLUME 10 · JANEIRO/MARÇO 2023; 24-30 ; 2184-0628 ; 2183-8135 ; 10.29315/gm.v10i1
Subject Terms: Metformina/usoterapêutico, Neoplasias da Próstata/mortalidade, Neoplasias da Próstata/ tratamento farmacológico, Metformin/therapeutic use, Prostatic Neoplasms/drug therapy, Prostatic Neoplasms/mortality
File Description: application/pdf
Relation: https://gazetamedica.pt/index.php/gazeta/article/view/653/414; https://gazetamedica.pt/index.php/gazeta/article/view/653
-
20
Authors: et al.
Subject Terms: Ablation Techniques/adverse effects, Ablation Techniques/methods, Disease Progression, Disease-Free Survival, Erectile Dysfunction/diagnosis, Erectile Dysfunction/epidemiology, Erectile Dysfunction/etiology, Humans, Lower Urinary Tract Symptoms/diagnosis, Lower Urinary Tract Symptoms/epidemiology, Lower Urinary Tract Symptoms/etiology, Male, Neoplasm Recurrence, Local/mortality, Local/pathology, Local/therapy, Neoplasm, Residual, Postoperative Complications/diagnosis, Postoperative Complications/epidemiology, Postoperative Complications/etiology, Prostate/pathology, Prostate/surgery, Prostatectomy/adverse effects, Prostatectomy/methods, Prostatic Neoplasms/mortality, Prostatic Neoplasms/pathology, Prostatic Neoplasms/therapy, Retreatment/adverse effects, Retreatment/methods
Relation: European Urology Oncology; https://iris.unil.ch/handle/iris/81743; serval:BIB_1014465520F4; 000484356200008
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science